RxDoctor Payments Data

Jonathan Ghormley, MD

Orthopaedic Surgery · Conway, ARNPI 1982696464

Payments from drug & device makers

$570in general payments, 2019–2025

Across 18 payments — averaging $31.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$169
  • Coloplast$92
  • Baudax Bio Inc.$66
  • Anika Therapeutics, Inc.$65
  • Zimmer Biomet$49
  • Smith+Nephew$42
  • plus $88 from 5 others

What the payments were for

  • Travel & lodging$13624%
  • Food & beverage$43476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker3$169
Coloplast1$92
Baudax Bio Inc.3$66
Anika Therapeutics, Inc.1$65
Zimmer Biomet1$49
Smith+Nephew3$42
Amgen(2 entities)2$31
Pacira Therapeutics, Inc.1$17
Acumed LLC1$16
Zimvie Inc.1$15
Kinex Medical Company LLC1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$570 in reported general payments places this provider in the 25th percentile of 168 orthopaedic surgery providers in Arkansas.

See all orthopaedic surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$129,231
Medicare patients
323
Services billed
7,606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium106$1,240
Oxycodone Hcl101$619
Celecoxib21$370
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$343
Tramadol Hcl18$107

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Conway

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →